GLP-2TZ 30mg is a synthetic dual-agonist research peptide widely utilized in laboratory and preclinical settings to investigate GLP-1 and GIP receptor pathway signaling, metabolic homeostasis, and incretin-mediated endocrine mechanisms. This 30mg formulation is commonly studied for its relevance in glucose-dependent insulin signaling, appetite regulation pathways, and adipose tissue metabolic models.  
 
Research applications frequently focus on intracellular cAMP pathway activation, glucagon suppression signaling, insulin secretagogue response models, and central appetite-center modulation. Additional studies examine its role in lipid metabolism, glucose utilization efficiency, and systemic energy homeostasis through dual receptor activation.  
 
Because of its extended-activity peptide analog structure, GLP-2TZ is frequently selected in controlled research environments evaluating multi-pathway metabolic signaling and long-acting receptor engagement dynamics.
 
This high-purity 30mg formulation is manufactured to strict laboratory standards and intended exclusively for analytical testing, in-vitro studies, and experimental research applications.
 
For research use only. Not for human consumption.
 
See product pictures for Certificates of Analysis.